A icle
The Se 7 Lysine Me hyl ans e ase Regula es
Plas ici y in Oxida i e Phospho yla ion Necessa y o
T ained Immuni y Induced by b-Glucan
G aphical Abs ac
Highligh s
dSe 7 egula es enhanced cy okine p oduc ion in ained
immuni y in i o
dSe 7 knockou mice a e unable o moun ained immuni y
agains endo oxin challenge
dSe 7 modula es cellula espi a ion in b-glucan- ained
mac ophages
dSe 7-dependen his one me hyla ion egula es MDH2 and
SDHB in ained cells
Au ho s
Samuel T. Kea ing, Laszlo G oh,
Cha lo e D.C.C. an de Heijden, ...,
Leo A.B. Joos en, Mihai G. Ne ea,
Niels P. Riksen
Co espondence
niels. iksen@ adboudumc.nl
In B ie
Using a combina ion o pha macological
and gene ic app oaches, Kea ing e al.
show ha he Se 7 me hyl ans e ase is a
egula o o ained immuni y induced by
b-glucan. Ac i a ion o Se 7 inc eases
oxida i e phospho yla ion in ained cells
ia his one lysine me hyla ion a gene
enhance s o key enzymes o he TCA
cycle.
Kea ing e al., 2020, Cell Repo s 31, 107548
Ap il 21, 2020 ª2020 The Au ho (s).
h ps://doi.o g/10.1016/j.cel ep.2020.107548
Cell Repo s
A icle
The Se 7 Lysine Me hyl ans e ase Regula es
Plas ici y in Oxida i e Phospho yla ion Necessa y
o T ained Immuni y Induced by b-Glucan
Samuel T. Kea ing,
1
Laszlo G oh,
1
Cha lo e D.C.C. an de Heijden,
1
Hanah Rod iguez,
2
Je
´ssica C. dos San os,
1
S ephanie Fanucchi,
3,4
Jun Okabe,
2
Ha ik ishnan Kaipananickal,
2,5
Jelme H. an Pu elen,
1,6
Leonie Helde ,
1
Ma lies P. Noz,
1
Vasiliki Ma za aki,
1
Yang Li,
1,7
L. Cha lo e J. de B ee,
1,8,9
Vale ie A.C.M. Koeken,
1
Simone J.C.F.M. Moo lag,
1
Ve a P. Mou i s,
1
Jo ge Domı
´nguez-And e
´s,
1
Ma ije Oos ing,
1
Elianne P. Bul huis,
10
We ne J.H. Koopman,
10
Musa Mhlanga,
3
Assam El-Os a,
2,5,11
Leo A.B. Joos en,
1,12
Mihai G. Ne ea,
1,13
and Niels P. Riksen
1,14,
*
1
Depa men o In e nal Medicine and Radboud Ins i u e o Molecula Li e Sciences (RIMLS), Radboud Uni e si y Medical Cen e , Nijmegen,
he Ne he lands
2
Epigene ics in Human Heal h and Disease, Depa men o Diabe es, Monash Uni e si y, Melbou ne, VIC, Aus alia
3
Di ision o Chemical, Sys ems and Syn he ic Biology, Depa men o In eg a i e Biomedical Sciences, Facul y o Heal h Sciences, Ins i u e o
In ec ious Disease and Molecula Medicine, Uni e si y o Cape Town, Cape Town, Sou h A ica
4
Gene Exp ession and Biophysics G oup, CSIR Biosciences, P e o ia, Sou h A ica
5
Depa men o Clinical Pa hology, The Uni e si y o Melbou ne, Melbou ne, VIC, Aus alia
6
Depa men o Heal h E idence, Radboud Uni e si y Medical Cen e , Nijmegen, he Ne he lands
7
Depa men o Compu a ional Biology o Indi idualised In ec ion Medicine, Cen e o Indi idualised In ec ion Medicine, Helmhol z Cen e
o In ec ion Resea ch, Hanno e Medical School, 30625 Hanno e , Ge many
8
Resea ch Cen e o Vi amins and Vaccines, Bandim Heal h P ojec , S a ens Se um Ins i u , Copenhagen, Denma k
9
Odense Pa ien Da a Explo a i e Ne wo k, Uni e si y o Sou he n Denma k/Odense Uni e si y Hospi al, Odense, Denma k
10
Depa men o Biochemis y, Radboud Ins i u e o Molecula Li e Sciences (RIMLS), Radboud Uni e si y Medical Cen e , Nijmegen, he
Ne he lands
11
P ince o Wales Hospi al, The Chinese Uni e si y o Hong Kong, Hong Kong Ci y, Hong Kong SAR
12
Depa men o Medical Gene ics, Iuliu Ha ieganu Uni e si y o Medicine and Pha macy, Cluj-Napoca, Romania
13
Depa men o Genomics and Immuno egula ion, Li e and Medical Sciences Ins i u e (LIMES), Uni e si y o Bonn, Bonn, Ge many
14
Lead Con ac
*Co espondence: niels. iksen@ adboudumc.nl
h ps://doi.o g/10.1016/j.cel ep.2020.107548
SUMMARY
T ained immuni y con e s a sus ained augmen ed
esponse o inna e immune cells o a seconda y
challenge, ia a p ocess dependen on me abolic
and ansc ip ional ep og amming. Because o
i s p e ious associa ions wi h me abolic and an-
sc ip ional memo y, as well as he impo ance o
H3 his one lysine 4 monome hyla ion (H3K4me1)
o inna e immune memo y, we hypo hesize ha
he Se 7 me hyl ans e ase has an impo an ole
in ained immuni y induced by b-glucan. Using
pha macological s udies o human p ima y mono-
cy es, we iden i y ained immuni y-speci ic
immunome abolic pa hways egula ed by Se 7,
including a p e iously un epo ed H3K4me1-
dependen plas ici y in he induc ion o oxida-
i e phospho yla ion. Recapi ula ion o b-glucan
aining in i o addi ionally iden i ies Se 7-depen-
den changes in gene exp ession p e iously asso-
cia ed wi h he modula ion o myelopoiesis p o-
geni o s in ained immuni y. By e ealing Se 7 as
a key egula o o ained immuni y, hese indings
p o ide mechanis ic insigh in o sus ained me a-
bolic changes and unde sco e he impo ance o
cha ac e izing egula o y ci cui s o inna e immune
memo y.
INTRODUCTION
A se ies o ecen disco e ies has unco e ed how cells o he
inna e immune sys em such as monocy es and mac ophages
unde go unc ional ep og amming o moun a de ac o immune
memo y o an in ec ious o in lamma o y inju y by a p ocess
called ained immuni y, which acili a es augmen ed esponses
o subsequen pa hogenic encoun e s (Ne ea e al., 2020). In he
con ex o in ec ions o accina ion, ained immuni y p o ides
bene icial he e ologous e ec s by he enhanced cy okine
esponse o s imula ion wi h non- ela ed pa hogens. P o o ypi-
cal s imuli o ained immuni y include he ungal cell wall compo-
nen b-glucan (Quin in e al., 2012) and he bacillus Calme e-
Gue
´ in (BCG) accine (Kleinnijenhuis e al., 2012). Recen a en-
ion has also u ned o endogenous d i e s o in lamma ion as in-
duce s o ained immuni y (Bekke ing e al., 2014; an de Valk
e al., 2016). These s imuli shape inna e immunological mem-
o ies by ep og amming me abolic and ansc ip ional p o iles
(A s e al., 2016a; Cheng e al., 2014).
Pos ansla ional me hyla ion o p o eins con eys in o ma-
ion o cellula pa hways, including hose ha egula e gene
Cell Repo s 31, 107548, Ap il 21, 2020 ª2020 The Au ho (s). 1
This is an open access a icle unde he CC BY-NC-ND license (h p://c ea i ecommons.o g/licenses/by-nc-nd/4.0/).
Figu e 1. Se 7 Is Associa ed wi h T ained Immuni y Induced by b-Glucan
(A) G aphical ou line o in i o aining me hods. Adhe en monocy es (Mo) we e s imula ed wi h 1 mg/mL b-glucan o s anda d cul u e medium (RPMI) o 24 h
( i s s imulus), allowed o di e en ia e o mac ophages (M4) o 5 days, and es imula ed o 24 h wi h LPS o RPMI on day 6.
(legend con inued on nex page)
2Cell Repo s 31, 107548, Ap il 21, 2020
exp ession. In i o expe imen s wi h pan-me hyl ans e ase
inhibi o s e ealed he pi o al impo ance o his chemical
modi ica ion o ained mac ophages (Cheng e al., 2014;
Quin in e al., 2012). Changes in his one lysine me hyl modi i-
ca ions (H3 his ones monome hyla ed [H3K4me1] o ime hy-
la ed [H3K4me3] a lysine 4) unde lie b-glucan-induced ained
immuni y (No ako ic e al., 2016). Signaling ac o s de i ed
om local issue en i onmen s play key oles in de e mining
mac ophage a e, and e idence poin s o he ole o enhance
elemen s in shaping specialized mac ophage popula ions
(Denisenko e al., 2017; Gosselin e al., 2014). H3K4me1 is a
ch oma in signa u e o enhance s (Hein zman e al., 2007).
This modi ica ion was shown o pe sis a decommissioned
dis al elemen s, indica ing ha H3K4me1 p o ides a mecha-
nism o epigene ic memo y in ained immuni y in mac o-
phages (Saeed e al., 2014). Despi e his, he mechanisms
linking immunological signals induced by mic obial s imuli
o accines o ch oma in-dependen changes in ained
immuni y a e unclea . Mo eo e , he iden i ies o he ch o-
ma in-modi ying enzymes c i ical o hese p ocesses emain
obscu e.
One enzyme ha w i es he H3K4me1 modi ica ion o
ansc ip ionally ac i a ing o poised genomic egions is
he Se 7 lysine me hyl ans e ase (Wang e al., 2001)(also
called Se 9 [Nishioka e al., 2002], Se 7/9 [Tamu a e al.,
2018], o KMT7 [Allis e al., 2007], and encoded by
SETD7). Se 7 w i es a pe sis en H3K4me1 signa u e pe ain-
ing o ascula endo helial in lamma o y signaling (B asacchio
e al., 2009). The impo ance o Se 7 o media ing H3K4me1
signa u es a enhance s associa ed wi h endo helial gene
exp ession was demons a ed using an unbiased epige-
nome-wide app oach (Kea ing e al., 2014). Al hough Se 7
has no been s udied in he speci ic con ex o ained immu-
ni y, ou p e ious analysis o mac ophages ained wi h
b-glucan iden i ied ele a ed le els o SETD7 exp ession (Quin-
in e al., 2012).
The cu en s udy explo ed he ole o Se 7 in b-glucan-
induced ained immuni y. Using gene ic and pha macological
app oaches, we demons a e ha Se 7 is c i ical o he induc-
ion o ained immuni y in i o and in i o. We iden i y a ole
o Se 7 in immunome abolic pa hways, including he induc ion
o oxida i e phospho yla ion (OXPHOS). Cha ac e iza ion o
epigene ic ne wo ks is key o a deepe unde s anding o egula-
o y mechanisms suppo ing ained immuni y, and could iden-
i y s a egies o modula e p o-in lamma o y ci cui s o he inna e
immune sys em.
RESULTS
Se 7 Exp ession and Ac i i y A e Inc eased in Human
P ima y Monocy es and Mac ophages S imula ed wi h
b-Glucan
To in es iga e he ole o Se 7, we adop ed a p e iously
desc ibed in i o model o ained immuni y using he ungal
cell wall componen b-glucan (Cheng e al., 2014). Adhe en hu-
man p ima y monocy es we e incuba ed wi h cul u e medium o
b-glucan (1 mg/mL) o 24 h. Cells we e washed and incuba ed in
no mal cul u e condi ions o a u he 5 days, du ing which ime
hey di e en ia ed in o mac ophages. On day 6, he cells we e
es imula ed wi h he Toll-like ecep o 4 ligand lipopolysaccha-
ide (LPS) (10 ng/mL) o 24 h and p o-in lamma o y cy okine p o-
duc ion was measu ed (Figu e 1A). Tumo nec osis ac o alpha
(TNFa) and IL-6 we e measu ed as unc ional eadou s o ained
immuni y (A s e al., 2016a; Cheng e al., 2014). Cells s imula ed
wi h b-glucan exhibi ed enhanced TNFaand IL-6 p oduc ion
ollowing LPS es imula ion (Figu e 1B). We alida ed ou p e i-
ous ansc ip ome da a showing ha SETD7 mRNA exp ession
was signi ican ly inc eased on day 6 o he in i o aining p o o-
col in mac ophages ained wi h b-glucan. Cu en ly, he e is no
gold s anda d es o Se 7 ac i i y in p ima y cells. Howe e , a
ecen s udy iden i ied he ibosomal p o ein Rpl29, a compo-
nen o he 60S ibosomal subuni , as a non-his one me hyla ion
subs a e o Se 7 (Hamidi e al., 2018), and dime hyla ed Rpl29
(Rpl29k5me2) was shown o se e as a eliable bioma ke o
Se 7 ac i i y in cance cells. We obse ed ha Rpl29k5me2
le els co ela ed wi h Se 7 p o ein exp ession in mac ophages
ained wi h b-glucan (Figu e 1C).
To u he in es iga e he associa ion o Se 7 o ained immu-
ni y, we conduc ed a gene ic s udy o pe iphe al blood mononu-
clea cells (PBMCs) isola ed om 267 heal hy olun ee s o
Wes e n Eu opean ances y. Adhe en PBMCs om all olun-
ee s we e incuba ed wi h ained wi h cul u e medium o
b-glucan (1 mg/mL) o 24 h as desc ibed abo e. We es ed o
associa ions among common single-nucleo ide polymo phisms
(SNPs) and a ia ion in he magni ude o b-glucan- ained cy o-
kine esponses o indi idual subjec s and iden i ied wo SNPs
sugges i ely associa ed (p < 9.99 310
3
) wi h adap i e changes
in cy okine p oduc ion mapped wi hin SETD7. In onic a ian s
s7680948 (loca ed in in on 4 o SETD7 [p < 0.004]) and
s56183115 (loca ed in in on 3 o SETD7 [p = 0.004]) we e asso-
cia ed wi h he po en ia ion o TNFaand IL-6 p oduc ion, espec-
i ely, upon induc ion o ained immuni y by b-glucan (Fig-
u e 1D). To in es iga e Se 7 in ained immuni y induced by
(B) P oduc ion o p o-in lamma o y cy okines TNFaand IL-6 by ained mac ophages ollowing es imula ion (n = 6 heal hy olun ee s pe g oup).
(C) Exp ession o SETD7 mRNA p io o es imula ion (6 d) (n = 7 heal hy olun ee s pe g oup). Rep esen a i e wes e n blo analysis o di e en ia ed mac o-
phages pe o med on day 6, p io o es imula ion. Se 7 encoded by he SETD7 gene; Rpl29k5me2 as a ma ke o Se 7 ac i i y; b-ac in was used as loading
con ol.
(D) Single-nucleo ide polymo phisms (SNPs) wi hin SETD7 sugges i ely associa ed wi h ained esponses o b-glucan in pe iphe al blood mononuclea cells (n =
267). Age- and sex-co ec ed TNFaand IL-6 changes a e shown as boxplo s o s7680948 and s56183115, espec i ely.
(E) SNPs nea SETD7 sugges i ely associa ed wi h ained esponses o he bacillus Calme e-Gue
´ in accine in pe iphe al blood mononuclea cells. Age- and
sex-co ec ed TNFaand IL-6 changes a e shown as boxplo s o s795971 (n = 213) and s6816973 (n = 248), espec i ely.
(F) SNPs nea SETD7 sugges i ely associa ed wi h ained esponses o he oxidized low-densi y lipop o ein in pe iphe al blood mononuclea cells. Age- and sex-
co ec ed TNFaand IL-6 changes a e shown as boxplo s o s6536295 (n = 197) and s10020166 (n = 225), espec i ely.
Da a a e ep esen ed as mean ±SEM. *p < 0.05, Wilcoxon signed- ank es .
Cell Repo s 31, 107548, Ap il 21, 2020 3
(legend on nex page)
4Cell Repo s 31, 107548, Ap il 21, 2020

o he s imuli, we es ed o associa ions among SNPs nea
SETD7 and a ia ion in he magni ude o cy okine esponses o
indi iduals ained wi h BCG and oxidized low-densi y lipop o-
ein (oxLDL). We iden i ied nume ous SNPs sugges i ely associ-
a ed (p < 9.99 310
3
) wi h adap i e changes in p o-in lamma-
o y cy okine p oduc ion mapped wi hin 250 kb o SETD7.
Va ian s s795971 (loca ed app oxima ely 250 kb ups eam o
SETD7 [p = 0.007]) and s6816973 (loca ed app oxima ely 160
kb ups eam o SETD7 [p < 0.003]) we e associa ed wi h he
po en ia ion o TNFaand IL-6 p oduc ion, espec i ely, upon in-
duc ion o ained immuni y by BCG (Figu e 1E). In addi ion, we
iden i ied ha a ian s s6536295 (loca ed app oxima ely 3 kb
ups eam o SETD7 [p < 0.007]) and s10020166 (loca ed
app oxima ely 15 kb ups eam o SETD7 [p = 0.01]) we e associ-
a ed wi h he p oduc ion o TNFaand IL-6, espec i ely, upon in-
duc ion o ained immuni y by oxLDL (Figu e 1F).
Pha macological Inhibi ion o Se 7 A enua es
b-Glucan-Induced T ained Immuni y In Vi o
Recen s udies demons a ed speci ic inhibi ion o Se 7 ac i i y
by cyp ohep adine (CPH) in human b eas cance cells (Take-
mo o e al., 2016). To es whe he CPH simila ly inhibi s Se 7
in p ima y cells, we measu ed Rpl29K5me2 le els o mac o-
phages ained wi h b-glucan and obse ed a s ong educ ion
o his pos ansla ional modi ica ion ollowing 24-h incuba ion
wi h 100 mM CPH (Figu e 2A). To cha ac e ize he e ec s o
CPH on ained immuni y, we conduc ed in i o aining expe i-
men s on monocy es exposed o a ange o CPH concen a ions
(Figu e 2B). When co-incuba ed wi h b-glucan o only he i s
24 h o he aining p o ocol, CPH dose-dependen ly a enua ed
he heigh ened esponsi eness o ained cells o es imula ion
wi h LPS (Figu es 2C and 2D). This e ec was mos p onounced
a he highes concen a ion o CPH es ed (100 mM); howe e , a
signi ican educ ion in TNFap oduc ion was obse ed a e co-
incuba ion wi h 25 mM CPH.
Simila inhibi ion o b-glucan-induced ained immuni y by
CPH (100 mM) was obse ed when he cells we e es imula ed
wi h he Toll-like ecep o 2 agonis Pam3Cys (10 mg/mL) (Fig-
u e 2E). Exposu e o his concen a ion o CPH did no al e he
mRNA exp ession o SETD7 (measu ed on day 6, p io o es im-
ula ion), indica ing ha he inhibi o y e ec on ained immuni y
occu ed a he le el o Se 7 ac i i y (Figu e 2F, open ba ep e-
sen s DMSO ehicle con ols). Simila ly, RPL29 mRNA exp es-
sion was una ec ed by 100 mM CPH (Figu e 2G, open ba ep e-
sen s DMSO ehicle con ols). The a enua ing e ec o CPH on
cy okine p oduc ion was no due o cy o oxici y o he com-
pound (Figu e 2H) o induc ion o apop osis (Figu e 2I). We
excluded he possibili y ha CPH inhibi s ained immuni y ia
i s an ihis amine p ope ies by pe o ming expe imen s using
an al e na i e an ihis amine inhibi o , diphenhyd amide, which
did no al e ained immuni y induced by b-glucan (Figu e S1).
To alida e he obse a ion o Se 7-dependen egula ion o
cy okine p oduc ion, we also es ed he Se 7 inhibi o sine ungin
(Sasaki e al., 2016). Sine ungin dose-dependen ly inhibi ed he
heigh ened p oduc ion o TNFaand IL-6 by ained cells
ollowing es imula ion wi h LPS (Figu es 2J and 2K). To es
he b oade ole o Se 7 as a key egula o o ained immuni y,
we assessed he e ec s o CPH on ained cy okine p oduc ion
by o he compounds p e iously shown o induce ained immu-
ni y. Indeed, incuba ion wi h 100 mM CPH also inhibi ed he in-
duc ion o ained immuni y by BCG (Figu e 2L). Simila ly, he
dec in-1 ligand lamina in was p e iously demons a ed o induce
ained immuni y (Pe i e al., 2019). He e, we show ha he
augmen ed TNFap oduc ion exhibi ed by mac ophages ained
wi h lamina in was inhibi ed by CPH. A simila end was
obse ed o IL-6 p oduc ion, wi h no di e ence obse ed be-
ween cells ha we e incuba ed wi h lamina in and CPH, o lami-
na in alone (Figu e 2M).
To unde s and he mechanism o Se 7-dependen cy okine
p oduc ion in ained immuni y, we assessed he TNF and IL6
Figu e 2. Pha macological Inhibi ion o Se 7 Dose-Dependen ly A enua es he P o-in lamma o y Cy okine Response o T ained Immuni y
In Vi o
(A) Wes e n blo analysis o b-glucan- ained mac ophages incuba ed wi h cyp ohep adine (CPH) o 24 h. HSP90 was used as a loading con ol.
(B) G aphical o e iew o in i o aining me hods. Adhe en monocy es (Mo) we e s imula ed wi h b-glucan o RPMI cul u e medium o 24 h in he p esence o
CPH o DMSO ehicle con ol, allowed o di e en ia e o mac ophages (M4), and es imula ed o 24 h wi h LPS, Pam3Cys, o RPMI on day 6.
(C and D) P oduc ion o (C) TNFaand (D) IL-6 by b-glucan- ained mac ophages incuba ed wi h CPH o 50-me hyl hioadenosine (MTA) o he i s 24 h o in i o
aining and es imula ed wi h LPS (n = 7 heal hy olun ee s).
(E) P oduc ion o TNFaby b-glucan- ained mac ophages incuba ed wi h CPH o he i s 24 h o in i o aining and es imula ed wi h Pam3Cys (n = 3 heal hy
olun ee s).
(F) Exp ession o SETD7 mRNA on day 6 by cells ained wi h b-glucan in he p esence o 100 mM CPH (n = 6 heal hy olun ee s; open ba ep esen s DMSO
ehicle con ol).
(G) Exp ession o RPL29 mRNA a 24 h by cells ained wi h b-glucan in he p esence o 100 mM CPH (n = 3 heal hy olun ee s; open ba ep esen s DMSO ehicle
con ol).
(H) Analysis o lac a e dehyd ogenase (LDH) as a measu e o cy o oxici y in cells incuba ed wi h 100 mM CPH o 24 h (n = 3 heal hy olun ee s).
(I) Analysis o iabili y and apop osis wi h Annexin V and PI s aining in cells incuba ed wi h 100 mM CPH e sus DMSO ehicle con ols o 24 h (n = 3 heal hy
olun ee s). Fold change di e ence be ween CPH and ehicle con ols.
(J and K) P oduc ion o (J) TNFaand (K) IL-6 by b-glucan- ained mac ophages incuba ed wi h sine ungin o he i s 24 h o in i o aining and es imula ed wi h
LPS (n = 6 heal hy olun ee s).
(L) P oduc ion o TNFaand IL-6 by bacillus Calme e-Gue
´ in (BCG)- ained mac ophages incuba ed wi h 100 mM CPH o he i s 24 h o in i o aining and
es imula ed wi h LPS (n = 6 heal hy olun ee s).
(M) P oduc ion o TNFaand IL-6 by lamina in- ained mac ophages incuba ed wi h 100 mM CPH o he i s 24 h o in i o aining and es imula ed wi h LPS (n = 6
heal hy olun ee s).
Da a a e ep esen ed as mean ±SEM. *p < 0.05, Wilcoxon signed- ank es o es whe e app op ia e.
See also Figu es S1 and S2.
Cell Repo s 31, 107548, Ap il 21, 2020 5
p omo e s by ch oma in immunop ecipi a ion (ChIP) on day 6.
We did no obse e signi ican inc eases in H3K4me1 en ich-
men a ei he p omo e in cells ained wi h b-glucan. A simila
pa e n o H3K4me1 en ichmen was obse ed o cells ained
in he p esence o 100 mM CPH (Figu e S2), sugges ing ha
Se 7 does no di ec ly egula e TNF and IL6 exp ession ia p o-
mo e his one me hyla ion.
Toge he , hese indings iden i y an impo an ole o Se 7 in
ained immuni y in i o.
Se 7 Regula es T ained Immuni y In Vi o
Using mu ine models, we and o he s (Cheng e al., 2014; Ga cia-
Val anen e al., 2017) ha e desc ibed he speci ic con ibu ion o
b-glucan o he ac i a ion o ained immuni y in i o. Wild- ype
mice ha ecei ed b-glucan injec ions exhibi ed enhanced cy o-
kine p oduc ion by inna e immune cells in esponse o a second-
a y challenge o in ec ion (A s e al., 2016a). We adop ed a
simila app oach o es he ole o Se 7 in ained immuni y
in i o. We gene a ed a Se 7 cons i u i e knockou (Se d7 KO)
mouse model by he dele ion o Se d7 exon 2 egion (unpub-
lished da a). Dele ion o exon 2, which encodes he i s MORN
(memb ane occupa ion and ecogni ion nexus) epea , esul s
in a ameshi and inac i a ion o Se 7. Wes e n blo and gene
exp ession analyses con i med ha Se 7 was absen in bone
ma ow (BM) o he homozygous Se d7 KO mice (Figu e 3A).
Wild- ype and Se d7 KO mice we e sys emically adminis e ed
a single in ape i oneal 1-mg dose o b-glucan as desc ibed p e-
iously (Cheng e al., 2014). Con ol mice we e injec ed wi h
endo oxin- ee phospha e-bu e ed saline (PBS). Fi e days a e
b-glucan adminis a ion, he mice we e challenged wi h in ape -
i oneal injec ions o 10 mg o LPS, and a e 3 h he se um le els o
cy okines we e quan i ied (Figu e 3B). Con as ing he
augmen ed p o-in lamma o y cy okine p oduc ion in wild- ype
mice adminis e ed b-glucan, mice lacking unc ional Se 7 we e
unable o moun ained immuni y agains endo oxin challenge
wi h ega d o TNFaand IL-1bp oduc ion. Howe e , he e ec s
o Se 7 dele ion on he ained p oduc ion o IL-6 in i o a e less
clea , because IL-6 p oduc ion was al eady a high le els in wild-
ype mice ha ecei ed PBS (Figu e 3C).
The modula ion o myeloid p ogeni o s is an in eg al compo-
nen o ained immuni y (Ch is e al., 2018; Kau mann e al.,
2018; Mi oulis e al., 2018), which can explain he sus ained ac i-
a ion o he inna e immune sys em beyond he sho li e span o
ci cula ing myeloid cells. A ecen s udy showed ha adminis a-
ion o b-glucan o mice esul ed in he expansion and pola iza-
ion o hema opoie ic s em and p ogeni o cells (HSPCs) owa d
myelopoiesis, which was associa ed wi h ele a ed signaling by
inna e immune media o s such as IL-1band g anulocy e-mac o-
phage colony-s imula ing ac o (GM-CSF), as well as changes in
lipid and glucose me abolism (Mi oulis e al., 2018). To in es i-
ga e he ole o Se 7 in hese adap a ions, we analyzed Se d7
mRNA in he BM o wild- ype mice and obse ed a end o in-
c ease exp ession in mice adminis e ed b-glucan (Figu e 3D).
We eplica ed key indings o he p e ious s udy (Mi oulis
e al., 2018), albei in whole bone ma ow, and ound ha
b-glucan-dependen ansc ip ional induc ion o Cs 2 (GM-
CSF) and Il1b was signi ican ly educed in Se d7 KO mice. We
also obse ed a educ ion in he exp ession o he su oga e
ma ke o HSPCs Cd34 in Se 7 null mice; howe e , he exp es-
sion o his gene emained ele a ed ela i e o Se 7-null mice ha
ecei ed PBS injec ions (Figu e 3E). These da a demons a e
ha Se 7 egula es he in i o p o-in lamma o y cy okine
esponse o induc ion o ained immuni y by b-glucan and indi-
ca e an impo an ole in hema opoie ic adap a ions ha suppo
he sus ained pheno ype.
Se 7 Regula es Key Me abolic Changes in Mac ophages
T ained wi h b-Glucan
T ained immuni y induced by b-glucan o BCG is cha ac e ized
by me abolic ep og amming including inc eased glycolysis
and in acellula accumula ion o uma a e and me alona e
(A s e al., 2016a; Bekke ing e al., 2018). To explo e he po en ial
ole o Se 7 in he hallma k glycoly ic me abolism o ained im-
muni y, we measu ed ex acellula lac a e le els in day 6 mac o-
phages ained wi h b-glucan. We obse ed a signi ican inc ease
in hese le els in b-glucan- ained cells ha was abolished by co-
incuba ion wi h 100 mM CPH o he i s 24 h o in i o aining
(Figu e 4A). In addi ion o changes in glycolysis, p e ious s udies
ound ha b-glucan aining is accompanied by he ep ession o
OXPHOS. In con as o hose indings (Cheng e al., 2014), we
obse ed inc eased oxygen consump ion a day 6 by cells ained
wi h 1 mg/mL b-glucan (Figu e 4B). By pe o ming pa allel espi-
ome y expe imen s wi h he Seaho se XF Ex acellula Flux
Analyze and he Oxyg aph-2k om O obo os ( he ins umen
used o measu ing oxygen consump ion by Cheng e al.,
2014), we ound ha he s imula o y dose o b-glucan can explain
he disc epancy be ween he cu en (inc eased oxygen con-
sump ion) and p e iously epo ed indings (dec eased oxygen
consump ion) (Cheng e al., 2014). Speci ically, we obse ed, us-
ing he Oxyg aph-2k, aining wi h 1 mg/mL b-glucan s imula ed
oxygen consump ion measu ed on day 6. On he o he hand,
he s imula o y dose o 10 mg/mL desc ibed by Cheng e al. led
o an o e all educ ion o oxygen consump ion by ained mac o-
phages (Figu es S3A and S3B). To con i m hese obse a ions
and o ule ou dono -speci ic a ia ion as he cause, we ained
cells om he same se o dono s wi h 1 mg/mL b-glucan o
10 mg/mL b-glucan and analyzed hem in pa allel using he Sea-
ho se sys em. While bo h s imula o y doses showed a end o in-
c ease he ex acellula acidi ica ion a e, aining wi h 1 mg/mL
b-glucan inc eased oxygen consump ion, whe eas aining wi h
10 mg/mL b-glucan educed oxygen consump ion o each dono
(Figu es S3C and S3D). Nex , we sough o de e mine whe he
Se 7 was mechanis ically in ol ed in he up egula ion o OX-
PHOS by cells ained wi h b-glucan. Pa alleling i s a enua ing
e ec on cy okine p oduc ion, CPH blun ed he inc ease in oxy-
gen consump ion induced by b-glucan (Figu e 4B; open ba s
ep esen DMSO ehicle con ols).
To unde s and he signi icance o his change in oxygen con-
sump ion o he induc ion o ained immuni y, we in es iga ed
he e ec o gene ic a ia ion on indi idual esponses o
b-glucan. D awing om ou gene ic s udy o PBMCs isola ed
om 267 heal hy olun ee s (coho 1; 300BCG), we es ed o
associa ions among common SNPs (mino allele equency
>5%) and a ia ion in he magni ude o b-glucan- ained TNFa
and IL-6 esponses o indi idual subjec s. Al hough genome-
wide signi ican cy okine quan i a i e ai loci (cQTLs) we e no
6Cell Repo s 31, 107548, Ap il 21, 2020
obse ed, we iden i ied nume ous SNPs sugges i ely associ-
a ed (p < 9.99 310
3
) wi h adap i e changes in p o-in lamma-
o y cy okine p oduc ion mapped wi hin 250 kb o genes ela ed
o OXPHOS as well as genes encoding key ica boxylic acid
(TCA) cycle enzymes. Va ia ion in genes encoding isoci a e de-
hyd ogenase enzymes was associa ed wi h he po en ia ion o
TNFap oduc ion upon aining wi h b-glucan. Simila ly, a ia ion
in genes ha encode subuni s o he succina e dehyd ogenase
Figu e 3. Se 7 Regula es T ained Immuni y Induced by b-Glucan In Vi o
(A) Rep esen a i e wes e n blo o Se 7 p o ein exp ession in he bone ma ow o wild- ype (WT) and Se d7 KO mice. b-Ac in was used as loading con ol.
Exp ession o Se d7 mRNA in he bone ma ow o WT and Se d7 KO mice (n = 7 mice pe g oup).
(B) Schema ic o e iew o in i o induc ion o ained immuni y by b-glucan.
(C) Plasma le els o TNFa, IL-6, and IL-1bin WT and Se d7 KO mice ained wi h PBS o b-glucan on day 1 and adminis e ed LPS on day 6 (n = 6–9 mice pe
g oup).
(D) Day 6 analysis o Se d7 mRNA exp ession in he bone ma ow o WT mice adminis e ed PBS o b-glucan (n = 7 mice pe g oup).
(E) Bone ma ow mRNA exp ession o Cs 2,Il1b, and Cd34 in WT and Se d7 KO mice ained wi h PBS o b-glucan on day 1 and adminis e ed LPS on day 6
(n = 6–7 mice pe g oup).
Da a a e ep esen ed as mean ±SEM. *p < 0.05, **p < 0.01, Mann-Whi ney es .
Cell Repo s 31, 107548, Ap il 21, 2020 7
(legend on nex page)
8Cell Repo s 31, 107548, Ap il 21, 2020
S.F., J.O., K.H., J.H. .P., L.H., M.P.N., L.C.J.d.B., V.A.C.M.K., S.J.C.F.M.M.,
V.P.M., J.D.-A., M.O., E.P.B., and W.J.H.K.; W i ing—O iginal D a , S.T.K.;
W i ing—Re iew and Edi ing, S.T.K., L.G., C.D.C.C. .d.H., J.C.d.S., S.F.,
J.O., J.H. .P., M.P.N., V.M., L.C.J.d.B., V.A.C.M.K., S.J.C.F.M.M., V.P.M.,
J.D.-A., M.O., E.P.B., W.J.H.K., L.A.B.J., M.G.N., and N.P.R.; Funding Acqui-
si ion, L.A.B.J., M.G.N., and N.P.R.; Supe ision, J.O., M.M., A.E.-O., L.A.B.J.,
M.G.N., and N.P.R.
DECLARATION OF INTERESTS
W.J.H.K. is a scien i ic ad iso o Khond ion (Nijmegen, he Ne he lands) and
o Fo i y The apeu ics. These subjec ma e expe s had no in ol emen in
he da a collec ion, analysis and in e p e a ion, w i ing o he manusc ip ,
and he decision o submi he manusc ip o publica ion.
Recei ed: Augus 21, 2019
Re ised: Janua y 31, 2020
Accep ed: Ma ch 31, 2020
Published: Ap il 21, 2020
REFERENCES
Adams, D., Al ucci, L., An ona akis, S.E., Balles e os, J., Beck, S., Bi d, A.,
Bock, C., Boehm, B., Campo, E., Ca icasole, A., e al. (2012). BLUEPRINT o
decode he epigene ic signa u e w i en in blood. Na . Bio echnol. 30,
224–226.
Allis, C.D., Be ge , S.L., Co e, J., Den , S., Jenuwien, T., Kouza ides, T., Pillus,
L., Reinbe g, D., Shi, Y., Shiekha a , R., e al. (2007). New nomencla u e o
ch oma in-modi ying enzymes. Cell 131, 633–636.
A s, R.J., No ako ic, B., Te Ho s , R., Ca alho, A., Bekke ing, S., Lachman-
das, E., Rod igues, F., Sil es e, R., Cheng, S.C., Wang, S.Y., e al. (2016a).
Glu aminolysis and uma a e accumula ion in eg a e immunome abolic and
epigene ic p og ams in ained immuni y. Cell Me ab. 24, 807–819.
A s, R.J.W., Ca alho, A., La Rocca, C., Palma, C., Rod igues, F., Sil es e, R.,
Kleinnijenhuis, J., Lachmandas, E., Gonc¸ al es, L.G., Belinha, A., e al. (2016b).
Immunome abolic pa hways in BCG-induced ained immuni y. Cell Rep. 17,
2562–2571.
Bekke ing, S., Quin in, J., Joos en, L.A., an de Mee , J.W., Ne ea, M.G., and
Riksen, N.P. (2014). Oxidized low-densi y lipop o ein induces long- e m p oin-
lamma o y cy okine p oduc ion and oam cell o ma ion ia epigene ic ep og-
amming o monocy es. A e ioscle . Th omb. Vasc. Biol. 34, 1731–1738.
Bekke ing, S., A s, R.J.W., No ako ic, B., Kou zelis, I., an de Heijden, C.,
Li, Y., Popa, C.D., Te Ho s , R., an Tuijl, J., Ne ea-Maie , R.T., e al. (2018).
Me abolic induc ion o ained immuni y h ough he me alona e pa hway.
Cell 172, 135–146.e9.
B asacchio, D., Okabe, J., Tikellis, C., Balce czyk, A., Geo ge, P., Bake , E.K.,
Calkin, A.C., B ownlee, M., Coope , M.E., and El-Os a, A. (2009). Hype glyce-
mia induces a dynamic coope a i i y o his one me hylase and deme hylase
enzymes associa ed wi h gene-ac i a ing epigene ic ma ks ha coexis on
he lysine ail. Diabe es 58, 1229–1236.
Cheng, S.C., Quin in, J., C ame , R.A., Shepa dson, K.M., Saeed, S., Kuma ,
V., Giama ellos-Bou boulis, E.J., Ma ens, J.H., Rao, N.A., Aghajani e ah, A.,
e al. (2014). mTOR- and HIF-1a-media ed ae obic glycolysis as me abolic
basis o ained immuni y. Science 345, 1250684.
Ch is , A., G€
un he , P., Lau e bach, M.A.R., Duewell, P., Biswas, D., Pelka, K.,
Scholz, C.J., Oos ing, M., Haendle , K., Baßle , K., e al. (2018). Wes e n die
igge s NLRP3-dependen inna e immune ep og amming. Cell 172, 162–
175.e14.
Denisenko, E., Gule , R., Mhlanga, M.M., Suzuki, H., B ombache , F., and
Schmeie , S. (2017). Genome-wide p o iling o ansc ibed enhance s du ing
mac ophage ac i a ion. Epigene ics Ch oma in 10,50.
El-Os a, A., B asacchio, D., Yao, D., Pocai, A., Jones, P.L., Roede , R.G.,
Coope , M.E., and B ownlee, M. (2008). T ansien high glucose causes pe sis-
en epigene ic changes and al e ed gene exp ession du ing subsequen no -
moglycemia. J. Exp. Med. 205, 2409–2417.
Fanucchi, S., and Mhlanga, M.M. (2019). Lnc-ing ained immuni y o ch o-
ma in a chi ec u e. F on . Cell De . Biol. 7,2.
Fanucchi, S., Fok, E.T., Dalla, E., Shibayama, Y., Bo
¨ ne , K., Chang, E.Y., S oy-
che , S., Imakae , M., G imm, D., Wang, K.C., e al. (2019). Immune genes a e
p imed o obus ansc ip ion by p oximal long noncoding RNAs loca ed in
nuclea compa men s. Na . Gene . 51, 138–150.
Fishile ich, S., Nudel, R., Rappapo , N., Hada , R., Plaschkes, I., Iny S ein, T.,
Rosen, N., Kohn, A., Twik, M., Sa an, M., e al. (2017). GeneHance : genome-
wide in eg a ion o enhance s and a ge genes in GeneCa ds. Da abase
(Ox o d) 2017, bax028.
Ga cia-Val anen, P., Guzman-Genuino, R.M., Williams, D.L., Hayball, J.D., and
Diene , K.R. (2017). E alua ion o ained immuni y by b-1, 3 (d)-glucan on mu-
ine monocy es in i o and du a ion o esponse in i o. Immunol. Cell Biol. 95,
601–610.
Gnaige , E. (2001). Bioene ge ics a low oxygen: dependence o espi a ion
and phospho yla ion on oxygen and adenosine diphospha e supply. Respi .
Physiol. 128, 277–297.
Gosselin, D., Link, V.M., Romanoski, C.E., Fonseca, G.J., Eichen ield, D.Z.,
Spann, N.J., S ende , J.D., Chun, H.B., Ga ne , H., Geissmann, F., and Glass,
C.K. (2014). En i onmen d i es selec ion and unc ion o enhance s con ol-
ling issue-speci ic mac ophage iden i ies. Cell 159, 1327–1340.
Hamidi, T., Singh, A.K., Veland, N., Vemulapalli, V., Chen, J., Ha dika , S., Bao,
J., F y, C.J., Yang, V., Lee, K.A., e al. (2018). Iden i ica ion o Rpl29 as a majo
subs a e o he lysine me hyl ans e ase Se 7/9. J. Biol. Chem. 293, 12770–
12780.
Hein zman, N.D., S ua , R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D.,
Ba e a, L.O., Van Calca , S., Qu, C., Ching, K.A., e al. (2007). Dis inc and p e-
dic i e ch oma in signa u es o ansc ip ional p omo e s and enhance s in he
human genome. Na . Gene . 39, 311–318.
Kau mann, E., Sanz, J., Dunn, J.L., Khan, N., Mendonc¸ a, L.E., Pacis, A.,
Tzelepis, F., Pe ne , E., Dumaine, A., G enie , J.C., e al. (2018). BCG educa es
hema opoie ic s em cells o gene a e p o ec i e inna e immuni y agains
ube culosis. Cell 172, 176–190.e19.
Kea ing, S.T., and El-Os a, A. (2013). T ansc ip ional egula ion by he Se 7
lysine me hyl ans e ase. Epigene ics 8, 361–372.
Kea ing, S.T., and El-Os a, A. (2015). Epigene ics and me abolism. Ci c. Res.
116, 715–736.
Kea ing, S.T., Ziemann, M., Okabe, J., Khan, A.W., Balce czyk, A., and El-
Os a, A. (2014). Deep sequencing e eals no el Se 7 ne wo ks. Cell. Mol.
Li e Sci. 71, 4471–4486.
Kea ing, S.T., an Diepen, J.A., Riksen, N.P., and El-Os a, A. (2018). Epige-
ne ics in diabe ic neph opa hy, immuni y and me abolism. Diabe ologia 61,
6–20.
Ken , W.J., Sugne , C.W., Fu ey, T.S., Roskin, K.M., P ingle, T.H., Zahle , A.M.,
and Haussle , D. (2002). The human genome b owse a UCSC. Genome Res.
12, 996–1006.
Kleinnijenhuis, J., Quin in, J., P eije s, F., Joos en, L.A., I im, D.C., Saeed, S.,
Jacobs, C., an Loenhou , J., de Jong, D., S unnenbe g, H.G., e al. (2012). Ba-
cille Calme e-Gue in induces NOD2-dependen nonspeci ic p o ec ion om
ein ec ion ia epigene ic ep og amming o monocy es. P oc. Na l. Acad.
Sci. USA 109, 17537–17542.
Li, Y., Reddy, M.A., Miao, F., Shanmugam, N., Yee, J.K., Hawkins, D., Ren, B.,
and Na a ajan, R. (2008). Role o he his one H3 lysine 4 me hyl ans e ase,
SET7/9, in he egula ion o NF-kappaB-dependen in lamma o y genes. Rele-
ance o diabe es and in lamma ion. J. Biol. Chem. 283, 26771–26781.
Li, Y., Oos ing, M., Deelen, P., Rican
˜o-Ponce, I., Smeekens, S., Jaege , M.,
Ma za aki, V., Swe z, M.A., Xa ie , R.J., F anke, L., e al. (2016). In e -indi id-
ual a iabili y and gene ic in luences on cy okine esponses o bac e ia and
ungi. Na . Med. 22, 952–960.
Mi oulis, I., Ruppo a, K., Wang, B., Chen, L.S., G zybek, M., G inenko, T.,
Eugs e , A., T oullinaki, M., Palladini, A., Kou zelis, I., e al. (2018). Modula ion
o myelopoiesis p ogeni o s is an in eg al componen o ained immuni y. Cell
172, 147–161.e12.
Cell Repo s 31, 107548, Ap il 21, 2020 15

Ne ea, M.G., Domı
´nguez-And e
´s, J., Ba ei o, L.B., Cha akis, T., Di angahi,
M., Fuchs, E., Joos en, L.A.B., an de Mee , J.W.M., Mhlanga, M.M., Mulde ,
W.J.M., e al. (2020). De ining ained immuni y and i s ole in heal h and dis-
ease. Na . Re . Immunol. Published online Ma ch 4, 2020. h ps://doi.o g/
10.1038/s41577-020-0285-6.
Nishioka, K., Chuiko , S., Sa ma, K., E djumen -B omage, H., Allis, C.D.,
Temps , P., and Reinbe g, D. (2002). Se 9, a no el his one H3 me hyl ans e -
ase ha acili a es ansc ip ion by p ecluding his one ail modi ica ions
equi ed o he e och oma in o ma ion. Genes De . 16, 479–489.
No ako ic, B., Habibi, E., Wang, S.Y., A s, R.J.W., Da a , R., Megchelen-
b ink, W., Kim, B., Kuzne so a, T., Kox, M., Zwaag, J., e al. (2016). be a-
Glucan e e ses he epigene ic s a e o LPS-induced immunological ole -
ance. Cell 167, 1354–1368.e14.
Okabe, J., O lowski, C., Balce czyk, A., Tikellis, C., Thomas, M.C., Coope ,
M.E., and El-Os a, A. (2012). Dis inguishing hype glycemic changes by Se 7
in ascula endo helial cells. Ci c. Res. 110, 1067–1076.
Pe i , J., Emb eg s, C.W.E., Fo lenza, M., and Wiege jes, G.F. (2019). E i-
dence o ained immuni y in a ish: conse ed ea u es in ca p mac ophages.
J. Immunol. 203, 216–224.
Quin in, J., Saeed, S., Ma ens, J.H.A., Giama ellos-Bou boulis, E.J., I im,
D.C., Logie, C., Jacobs, L., Jansen, T., Kullbe g, B.J., Wijmenga, C., e al.
(2012). Candida albicans in ec ion a o ds p o ec ion agains ein ec ion ia
unc ional ep og amming o monocy es. Cell Hos Mic obe 12, 223–232.
Saeed, S., Quin in, J., Ke s ens, H.H., Rao, N.A., Aghajani e ah, A., Ma a ese,
F., Cheng, S.C., Ra e , J., Be en sen, K., an de En , M.A., e al. (2014).
Epigene ic p og amming o monocy e- o-mac ophage di e en ia ion and
ained inna e immuni y. Science 345, 1251086.
Sasaki, K., Doi, S., Nakashima, A., I i uku, T., Yamada, K., Koko oishi, K.,
Ueno, T., Doi, T., Hida, E., A ihi o, K., e al. (2016). Inhibi ion o SET domain-
con aining lysine me hyl ans e ase 7/9 amelio a es enal ib osis. J. Am.
Soc. Neph ol. 27, 203–215.
S adhoude s, R., Filion, G.J., and G a , T. (2019). T ansc ip ion ac o s and 3D
genome con o ma ion in cell- a e decisions. Na u e 569, 345–354.
Takemo o, Y., I o, A., Niwa, H., Okamu a, M., Fujiwa a, T., Hi ano, T., Handa,
N., Umeha a, T., Sonoda, T., Ogawa, K., e al. (2016). Iden i ica ion o cyp o-
hep adine as an inhibi o o SET domain con aining lysine me hyl ans e ase
7/9 (Se 7/9) ha egula es es ogen-dependen ansc ip ion. J. Med. Chem.
59, 3650–3660.
Tamu a, R., Doi, S., Nakashima, A., Sasaki, K., Maeda, K., Ueno, T., and Ma-
saki, T. (2018). Inhibi ion o he H3K4 me hyl ans e ase SET7/9 amelio a es
pe i oneal ib osis. PLoS ONE 13, e0196844.
ande Valk,F.M.,Bekke ing,S.,K oon,J.,Yeang,C.,VandenBossche,J.,
an Buul, J.D., Ra andi, A., Nede een, A.J., Ve be ne, H.J., Scipione, C.,
e al. (2016). Oxidized phospholipids on lipop o ein(a) elici a e ial wall
in lamma ion and an in lamma o y monocy e esponse in humans. Ci cula-
ion 134, 611–624.
Wang, H., Cao, R., Xia, L., E djumen -B omage, H., Bo che s, C., Temps , P.,
and Zhang, Y. (2001). Pu i ica ion and unc ional cha ac e iza ion o a his one
H3-lysine 4-speci ic me hyl ans e ase. Mol. Cell 8, 1207–1217.
Wang, Y., Song, F., Zhang, B., Zhang, L., Xu, J., Kuang, D., Li, D., Choudha y,
M.N.K., Li, Y., Hu, M., e al. (2018). The 3D Genome B owse : a web-based
b owse o isualizing 3D genome o ganiza ion and long- ange ch oma in in-
e ac ions. Genome Biol. 19, 151.
Wein aub, A.S., Li, C.H., Zamudio, A.V., Sigo a, A.A., Hanne , N.M., Day,
D.S., Ab aham, B.J., Cohen, M.A., Nabe , B., Buckley, D.L., e al. (2017).
YY1 is a s uc u al egula o o enhance -p omo e loops. Cell 171, 1573–
1588.e28.
Zhang, W.J., Wu, X.N., Shi, T.T., Xu, H.T., Yi, J., Shen, H.F., Huang, M.F.,
Shu, X.Y., Wang, F.F., Peng, B.L., e al. (2016). Regula ion o ansc ip ion
ac o Yin Yang 1 by SET7/9-media ed Lysine me hyla ion. Sci. Rep. 6,
21718.
16 Cell Repo s 31, 107548, Ap il 21, 2020
STAR+METHODS
KEY RESOURCES TABLE
REAGENT o RESOURCE SOURCE IDENTIFIER
An ibodies
Rabbi monoclonal an i-mono-me hyl-His one H3 (Lys4) Cell Signaling Technology Ca #5326; RRID: AB_10695148
Rabbi monoclonal an i-di-me hyl-Rpl29 (Lys5) Cell Signaling Technology Ca #19495; RRID: AB_2798819
Rabbi polyclonal an i-Se 7 Cell Signaling Technology Ca #2813; RRID: AB_823636
Rabbi polyclonal an i-HSP90 Cell Signaling Technology Ca #4874; RRID: AB_2121214
Rabbi polyclonal an i-b-ac in Sigma-Ald ich Ca #A2066; RRID: AB_476693
Mouse monoclonal an i-b-ac in Cell Signaling Technology Ca #3700; RRID: AB_2242334
swine-an i- abbi Ig polyclonal seconda y HRP an ibody Dako Ca #P0217; RRID: AB_2728719
Chemicals, Pep ides, and Recombinan P o eins
b-glucan (b1,3-(D)-glucan P o esso Da id Williams,
College o Medicine, Johnson
Ci y, USA
N/A
Lipopolysaccha ide Sigma-Ald ich Ca #L2880 F om E.coli se o ype 055:B5
Pe coll Sigma-Ald ich Ca #P1644
Ficoll-Paque GE Heal hca e Ca #17-1440-03
Roswell Pa k Memo ial Ins i u e medium (RPMI) In i ogen Ca #22406031
iSc ip e e se ansc ip ase Bio-Rad Ca #1708840
TRIzol eagen Li e Technologies Ca #15596018
SYBR G een Applied Biosciences Ca #4368708
16% Fo maldehyde Fishe Scien i ic Ca #28908
Cyp ohep adine Selleckchem Ca #S2044
Sine ungin Sigma-Ald ich Ca #S8559
Bacillus Calme e–Gue
´ in accine S a ens Se um Ins i u ,
Copenhagen, Denma k
N/A
Lamina in Sigma-Ald ich Ca #L9634
Diphenhyd amide hyd ochlo ide Sigma-Ald ich Ca #D3630
C i ical Comme cial Assays
Pie ce BCA p o ein assay ki The moFishe Scien i ic Ca #23225
Human TNFaDuoSe ELISA R&D sys ems Ca #DY210
Human IL-6 DuoSe ELISA R&D sys ems Ca #DY206
Mouse TNFaQuan ikine ELISA R&D sys ems Ca #MTA00B
Mouse IL-6 Quan ikine ELISA R&D sys ems Ca #M6000B
Mouse IL-1bQuan ikine ELISA R&D sys ems Ca #MLB00C
Lac a e Fluo ome ic Assay ki Bio ision Ca #K607
MinElu e PCR pu i ica ion column QIAGEN Ca #28006
iSc ip cDNA syn hesis ki Bio-Rad Ca #1708891
Cy ox 96 assay P omega Ca #G1780
Succina e colo ime ic assay ki Sigma-Ald ich Ca #MAK184
Fuma a e colo ime ic assay ki Sigma-Ald ich Ca #MAK060
Mala e colo ime ic assay ki Sigma-Ald ich Ca #MAK067
Oxaloace a e colo ime ic assay ki Sigma-Ald ich Ca #MAK070
Ci a e colo ime ic assay ki Sigma-Ald ich Ca #MAK057
Expe imen al Models: O ganisms/S ains
300BCG coho (Human Func ional Genomics P ojec ) N/A h ps://www.human unc ionalgenomics.o g
200FG coho (Human Func ional Genomics P ojec ) N/A h ps://www.human unc ionalgenomics.o g
(Con inued on nex page)
Cell Repo s 31, 107548, Ap il 21, 2020 e1
RESOURCE AVAILABILITY
Lead Con ac
Fu he in o ma ion and eques s o esou ces and eagen s should be di ec ed o and will be ul illed by he Lead Con ac , Niels P.
Riksen ([email p o ec ed]).
Ma e ials A ailabili y
This s udy did no gene a e new unique eagen s.
Da a and Code A ailabili y
This s udy did no gene a e any unique da ase s o code.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human subjec s
Wi h ega d o he in i o s udies, bu y coa s om male and emale heal hy dono s we e ob ained a e w i en in o med consen
(Sanquin blood bank, Nijmegen, he Ne he lands). Cells we e isola ed and expe imen s conduc ed on he same day.
Human coho s
The 300BCG coho consis s o 267 heal hy males and emales o Wes e n Eu opean ances y. The second coho consis s o
119 heal hy indi iduals o Wes e n Eu opean ances y om he 200 Func ional Genomics coho (2011/399) o he Human Func ional
Genomics P ojec . The 300BCG coho and 200FG coho s udies we e app o ed by he local e hics commi ee (CMO egio A nhem-
Nijmegen, numbe NL58553.091.16 and numbe 2011-399, espec i ely). Inclusion o olun ee s and expe imen s we e conduc ed
acco ding o he p inciples exp essed in he Decla a ion o Helsinki. All olun ee s ga e w i en in o med consen be o e any ma e ial
was aken.
Mice
The Se d7 knockou (KO) mice we e gene a ed by genOway (Lyon, F ance). The Se d7 a ge ing ec o was designed wi hin he i s
MORN domain o exon 2 con aining wo loxP si es (unpublished da a). Inse ion o loxP si es was in oduced 1.6kb ups eam o exon
2 by he in eg a ion o a loxP- lanked neomycine casse e. A a ge ing ec o con aining loxP si es lanking exon 2 o he Se d7 gene
was in eg a ed by homologous ecombina ion in mouse emb yonic s em cells. Recombinan clones we e injec ed in o mouse
C57BL/6J s ain blas ocys s and implan ed in o pseudop egnan emales. Once he cons uc was in eg a ed in o C57BL/6J back-
g ound mice, i was c ossed wi h a CMV p omo e -d i en C e ecombinase mouse o c ea e a cons i u i e Se d7 KO mouse. Wild-
ype and Se d7 KO mice housed unde speci ic pa hogen- ee condi ions we e used a he age o 9-11 weeks. Food and wa e was
p o ided ad libi um. All animal s udies we e app o ed by he Al ed Medical Resea ch and Educa ion P ecinc (AMREP) Animal E hics
Commi ee unde guidelines laid down by he Na ional Heal h and Medical Resea ch Council (NHMRC) o Aus alia.
METHOD DETAILS
Cells and eagen s
Human pe iphe al blood mononuclea cells (PBMCs) we e isola ed om heal hy olun ee s by densi y-g adien cen i uga ion
o e Ficoll-Paque (GE Heal hca e). Pe coll isola ion o monocy es was pe o med as p e iously desc ibed (A s e al., 2016a). Cells
we e cul u ed in RPMI 1640 Du ch-modi ied cul u e medium (RPMI medium, In i ogen) supplemen ed wi h 10 mg/mL gen amicin
(Cen a o m), 2 mM Glu amax (In i ogen), 1 mM py u a e (In i ogen), and 10% pooled human se um. S imuli and inhibi o s used
we e Esche ichia coli lipopolysaccha ide (LPS; se o ype 055:B5, Sigma-Ald ich, 10 ng/mL), and Pam3Cys (EMC mic ocollec ions,
Con inued
REAGENT o RESOURCE SOURCE IDENTIFIER
Se d7 knockou mouse P o esso Assam El-Os a,
Monash Uni e si y, Melbou ne
N/A
Oligonucleo ides
See Table S1 This pape N/A
So wa e and Algo i hms
G aphPad P ism 8.12 G aphpad so wa e h ps://www.g aphpad.com
R s a is ical p og amming N/A RRID:SCR_001905
e2 Cell Repo s 31, 107548, Ap il 21, 2020
L2000, 10 mg/mL), Lamina in (Sigma), BCG (S a ens Se um Ins i u , Copenhagen, Denma k), cyp ohep adine (Selleckchem), sine un-
gin (Sigma), and diphenhyd amide (Sigma).
In i o aining and pha macological inhibi ion
b-1,3-(D)-glucan (b-glucan) was kindly p o ided by P o esso Da id Williams (College o Medicine, Johnson Ci y, USA). Fo isola ion
o cell wall b-glucans C. albicans was cul i a ed in 25 mL o YPD (1% yeas ex ac , 2% dex ose, 2% pep one) o 48 hou s a 30C.
The cells we e ha es ed by cen i uga ion a 5,000x g o 5 minu es and pelle washed once wi h dH
2
O. The washed cell pelle s we e
hen ozen a 20C o e nigh . P io o ex ac ing he cell wall b-glucans, he cell pelle s we e subjec ed o epea ed eeze- haw
cycles (3X) o lyse he cells. Cell pelle s we e hen ex ac ed wi h a base/acid isola ion app oach. The supe na an con ained he wa e
soluble mannans. Glucans a e wa e insoluble and we e ha es ed by cen i uga ion and washing in dH
2
O p io o lyophiliza ion. The
s uc u e and pu i y o he b-glucans was de e mined by solu ion, high ield one and wo-dimensional Nuclea Magne ic Resonance
Spec oscopy (1 and 2-D NMR).
Adhe en monocy es we e ained as desc ibed p e iously (Bekke ing e al., 2014). Cells we e incuba ed wi h b-glucan (1 mg/mL),
Lamina in (1 mg/mL), o BCG (5 mg/mL) o 24 hou s, washed wi h wa m phospha e bu e ed saline (PBS) and incuba ed in no mal
cul u e medium a 37C, 5% CO
2
. Fo pha macological inhibi ion expe imen s, cells we e p e-incuba ed wi h cyp ohep adine (25-
100 mM), sine ungin (1, 10, 50, and 100 mg/mL), o diphenhyd amide (10, 50, 100 mg/mlL), o 1 hou p io o s imula ion. Following
5 days in cul u e, cells we e es imula ed wi h medium alone, 10 ng/mL LPS, o 10 mg/mL Pam3Cys o 24 hou s a 37C, 5%
CO
2
. Cy okine p oduc ion was measu ed in supe na an s by enzyme-linked immunoso ben assay (ELISA) acco ding o he manu-
ac u e ’s ins uc ions (R&D Sys ems).
Cy okine measu emen
Cy okine p oduc ion in supe na an s and plasmas was de e mined using comme cial enzyme-linked immunoso ben assay ki s o
TNFa, IL-6, IL-1b(R&D Sys ems, MN, USA), IL-10 (Sanquin) acco ding o he ins uc ions o he manu ac u e s.
Annexin V/PI s aining and lac a e dehyd ogenase (LDH) measu emen s o cell iabili y
Apop osis and cell iabili y o monocy es a e 24h exposu e o 100 mM CPH o ehicle con ol was e alua ed wi h Annexin V-FITC
(Bio ision) and P opidium Iodide ECD (Bio ision) luo escence wi h cy oFLEX low cy ome e (Beckman Coul e ) and analyzed wi h
Kaluza 2.1 (Beckman Coul e ). Analysis o LDH as a measu e o cy o oxici y in cells incuba ed wi h CPH o 24 hou s was assessed in
he supe na an s by using a Cy o ox 96 ki (P omega).
Quan i a i e RT-PCR
To al RNA was isola ed om human p ima y mac ophages and o al bone ma ow o mice using TRIzol eagen acco ding o he man-
u ac u e ’s ins uc ions. 0.5-1 mg o o al RNA was used o syn hesize cDNA wi h he Supe Sc ip III Fi s -S and Syn hesis Sys em
(The mo Fishe Scien i ic) acco ding o he manu ac u e ’s p o ocol. Quan i a i e RT-PCR was pe o med using an Applied Biosci-
ences S epOne PLUS qRT-PCR machine using SYBR G een (In i ogen). All eac ions we e pe o med o a leas 6 biological ep-
lica es and he alues exp essed as old inc ease in mRNA le els ela i e o hose in non- ained cells. 18s (human) o H3 3a (mouse)
was used as a housekeeping gene. qRT-PCR p ime s a e lis ed in Table S1.
Wes e n blo analysis o p ima y human cells
Fo p o ein exp ession analysis o p ima y human cells, app oxima ely 1 310
6
monocy es exposed o 24 hou s o 100 mM CPH and
1310
6
mac ophages we e lysed wi h 100 mL o lysis bu e (1M T is pH 7.4), 5M NaCl, 0.5M EDTA, 10% NP-40, 0.5M NaF, 2.5%
sodium deoxychola e, PhosSTOP (Roche), cOmple e (Roche)) p io o s imula ion on day 6. The homogena e was ozen, hen
hawed and cen i uged a 4C o 10 min a 15,000 x g, and he supe na an was aken o analysis. The wes e n blo was pe o med
using a T ans Tu bo Blo Sys em (Bio-Rad) acco ding o he manu ac u e ’s ins uc ions. P o ein was loaded and sepa a ed on SDS-
PAGE using 4%–15% g adien p ecas gels and ans e ed o ni ocellulose memb anes using he semi-d y me hod (Bio-Rad). Rab-
bi polyclonal p ima y an ibodies we e used o bo h Se 7 (1:1000, 2813, Cell Signaling Technology) and Rpl29k5me2 (1:1000, 19495,
Cell Signaling Techonolgy. Swine-an i- abbi polyclonal seconda y HRP an ibody (1:5000, P0217, Dako) was used o de ec Se 7 and
Rpl29k5me2 p o ein exp essions. b-ac in was de ec ed on he blo s using abbi polyclonal p ima y an ibody (1:1000, A2066, Sigma-
Ald ich) and swine-an i- abbi polyclonal seconda y HRP an ibody (1:5000, P0217, Dako). HSP90 was de ec ed on he blo s using
abbi polyclonal p ima y an ibody (1:1000, 4874, Cell Signaling Technology) and swine-an i- abbi polyclonal seconda y HRP an i-
body (1:5000, P0217, Dako). Blo s we e de eloped wi h ECL (GE Heal hca e) acco ding o he manu ac u e ’s ins uc ions.
Mouse expe imen s
Fo he in i o s udy o ained immuni y, mice we e injec ed in ape i oneally wi h 1 mg o b-glucan in 200 mL o endo oxin- ee phos-
pha e-bu e ed saline (PBS). In ape i oneal injec ions o PBS we e pe o med as con ol. Fi e days a e b-glucan adminis a ion, he
mice we e injec ed in ape i oneally wi h 10 mg o LPS om E. coli 055:B5 (Sigma) as a seconda y challenge. Mice we e eu hanized a
3 hou s a e he LPS challenge.
Cell Repo s 31, 107548, Ap il 21, 2020 e3
To isola e bone ma ow cells (BMCs), mouse emu s and ibias we e collec ed, immed and lushed wi h DPBS (GIBCO) using a
20 mL sy inge wi h a 25 gauge needle o elease BMCs. Bone ma ow suspensions we e gen ly ha es ed on 40 mm nylon mesh
s aine (Falcon) in 50 mL conical ubes. A e cen i uga ion (5 min, 350 x g,4
C), he cells we e suspended wi h RBC lysis bu e
(155 mM NH
4
Cl, 10 mM KHCO
3
, 0.1mM EDTA) o emo e e y h ocy es.
P o ein analyses we e pe o med as desc ibed p e iously (Okabe e al., 2012). B ie ly, app oxima ely 5 310
6
BMCs we e lysed
wi h 250 mL o bu e C (20 mM HEPES-KOH (pH 7.5), 25% Glyce ol, 520 mM KCl, 5 mM MgCl
2
, 0.1 mM EDTA, 1mM DTT,
0.5 mM PMSF, 0.2% NP-40 and p o einase inhibi o cock ail) o 15 min a 4C, hen cen i uged o 15 min a 15,000 x g,4
C.
The supe na an was collec ed o analysis. P ima y an ibodies we e used o bo h Se 7 (1:2,000, 2813, Cell Signaling Technology)
and b-ac in (1:10,000, 3700, Cell Signaling Technology). IRDye 800CW Donkey an i-mouse IgG and IRDye 680RD Donkey an i- abbi
IgG seconda y an ibodies (1:10,000 each, LI-COR) we e used o de ec Se 7 and b-ac in p o ein signals simul aneously.
Me abolic analysis
App oxima ely 1 310
7
monocy es we e ained wi h b-glucan (1 mg/mL) in 10 cm Pe i dishes (G eine ) in 10 mL medium olumes o
24 hou s, washed wi h wa m PBS and incuba ed in no mal cul u e medium a 37C, 5% CO
2
. Following 5 days in cul u e, cells we e
de ached wi h e sene solu ion (The moFishe Scien i ic) and 1 310
5
cells we e pla ed o o e nigh -calib a ed ca idges in assay
medium (RPMI wi h 0.6 mM glu amine, 5 mM glucose and 1 mM py u a e [pH adjus ed o 7.4]) and incuba ed o 1 hou in a non-CO
2
-
co ec ed incuba o a 37C. Oxygen consump ion a e (OCR) was measu ed using a Cell Mi o S ess Ki ( o OCR) o a glycolysis
s ess es ki in an XFp Analyze (Seaho se Bioscience), wi h inal concen a ions o 1 mM oligomycin, 1 mM FCCP, and 0.5 mM o e-
none/an imycin A.
Oxygen consump ion measu emen
Cul u e medium was collec ed om cells ea ed wi h ei he RPMI o b-glucan (1 mg/mL o 10 mg/mL). A e s imula ion, he cells we e
ypsinized, washed, and esuspended in he collec ed cul u e medium. Cell suspensions con aining 1 310
6
cells we e hen used o
cellula O
2
consump ion analysis. Oxygen consump ion was measu ed a 37C using pola og aphic oxygen senso s in a wo-cham-
be Oxyg aph (OROBOROS Ins umen s, Innsb uck, Aus ia). Da Lab so wa e (O obo os) was used o da a acquisi ion (2 s ime in-
e al) and analysis (Gnaige , 2001). Fi s , basal espi a ion (baseline oxygen consump ion) was measu ed. Nex , leak espi a ion was
de e mined by addi ion o 2.5 mM o he speci ic complex V inhibi o oligomycin A (OLI). Then, maximal elec on anspo chain com-
plex (ETC) capaci y (maximum oxygen consump ion) was quan i ied by applying inc easing concen a ions o he mi ochond ial un-
couple FCCP (0.25 o 20 mM inal maximal concen a ion). Finally, minimal (non-mi ochond ial) espi a ion was assessed by addi ion
o he speci ic complex I inhibi o o enone (ROT; 100 nM) and he complex III inhibi o an imycin A (AA; 2.5 mM).
Me aboli e measu emen s
Cells we e ained wi h b-glucan (1 mg/mL) wi h and wi hou CPH (100 mM) as desc ibed abo e, using DMSO as a ehicle con ol.
Me aboli e concen a ions measu ed om a leas 1 310
6
ained monocy es o succina e, uma a e, mala e, oxaloace a e, and ci -
a e we e de e mined using a comme cial colo ime ic assay ki (Sigma) acco ding o he manu ac u e ’s ins uc ions.
Gene ic analysis
We conduc ed in i o b-glucan, BCG and oxLDL aining o adhe en PBMCs om 267 heal hy indi iduals o Wes e n Eu opean
ances y om he 300BCG coho (NL58553.091.16). DNA samples o hese indi iduals we e geno yped using he comme cially
a ailable SNP chip, In inium Global Sc eening A ay MD 1.0 om Illumina. Geno ype in o ma ion on app oxima ely 4 million sin-
gle-nucleo ide polymo phisms (SNPs) was ob ained upon impu a ion (MAF > 5% and R
2
> 0.3 o impu a ion quali y). Fi s , aw cy o-
kine le els we e log- ans o med and he a io be ween ained and non- ained cy okine le els we e aken as he change o cy okine
le els. The cy okine changes we e mapped o geno ype da a using a linea eg ession model wi h age and sex as co a ia es. Gene ic
ou lie s (n = 15) and samples s imula ed wi h low b-glucan (< 1 mg/mL) we e emo ed be o e QTL mapping.
We also conduc ed in i o b-glucan aining o adhe en PBMCs in a second coho o 119 heal hy indi iduals o Wes e n Eu opean
ances y om he 200 Func ional Genomics coho (2011/399) o he Human Func ional Genomics P ojec (www.
human unc ionalgenomics.o g). Geno ype in o ma ion on app oxima ely 4 million single-nucleo ide polymo phisms (SNPs) was ob-
ained using Illumina HumanOmniExp essExome SNP chip upon impu a ion. Only SNPs wi h a mino allele equency o R5% ha
passed s anda d quali y il e s we e included in he analysis. Raw cy okine le els we e log- ans o med and he a io be ween ained
and non- ained cy okine le els was used o quan i y he ained immuni y esponse. They we e subsequen ly mapped o geno ype
da a using a linea eg ession model wi h age and sex as co- a ia es (Li e al., 2016).
ChIP-seq and ChIA-PET analysis
This s udy makes use o H3K4me1 ChIP-seq da ase s gene a ed by he Bluep in Conso ium (Adams e al., 2012). This s udy makes
use o ChIA-PET da a (accession numbe GSM970213). In he g aphical display o he ChIA-PET da a, he pai ed end ags (PETs) o
ch omosomal in e ac ions a e ep esen ed by wo blocks o each end o he con ac , connec ed by a ho izon al line. The numbe o
PETs in a clus e e lec s he s eng h o he ch omosomal in e ac ion. The p e-p ocessed da ase s we e isualized using he UCSC
genome b owse wi h he GRCh37/hg19 assembly (Ken e al., 2002). Enhance s we e iden i ied om he GeneHance da abase o
e4 Cell Repo s 31, 107548, Ap il 21, 2020

human egula o y elemen s (Fishile ich e al., 2017). Enhance s wi h he highes anno a ion-de i ed con idence sco e we e selec ed.
The s udy makes use o Hi-C da a om he K562 cell line (accession GSE63525). Hi-C maps we e gene a ed a 5kb esolu ion using
he 3D genome b owse wi h he GRCh37/hg19 assembly (Wang e al., 2018).
Ch oma in immunop ecipi a ion
T ained monocy es on day 6 we e c oss-linked in me hanol ee 1% o maldehyde, ollowed by sonica ion and immunop ecipi a ion
using an ibodies agains H3K4me1 (Cell Signaling Technology). Immunop ecipi a ed ch oma in was p ocessed u he o qRT-PCR
analysis using he MiniElu e DNA pu i ica ion ki (QIAGEN). P ime s used in he eac ion a e lis ed in Table S1. Samples we e analyzed
wi h a compa a i e C me hod on he S epOne PLUS qPCR machine (Applied Biosys ems) using SYBR g een (In i ogen) in acco -
dance wi h he manu ac u e ’s ins uc ions.
QUANTIFICATION AND STATISTICAL ANALYSIS
S a is ical pa ame e s including he exac alue o n, he de ini ion o cen e , dispe sion and p ecision measu es (mean ±SEM), and
s a is ical signi icance a e epo ed in he igu es and igu e legends. S a is ical analysis was pe o med using G aphPad P ism 8.12
(G aphPad Inc.). Analysis o human qPCR, ELISA and cellula assays was pe o med using Wilcoxon signed- ank es , es o non-
pa ame ic Mann-Whi ney es s, as app op ia e. Analysis o mouse da a used Mann-Whi ney es s o compa isons be ween g oups.
R-package Ma ix-eQTL was used o cy okine QTL mapping. A p alue < 0.05 (*) was conside ed s a is ically signi ican , (**) p < 0.01.
Da a a e shown as mean ±SEM.
Cell Repo s 31, 107548, Ap il 21, 2020 e5